This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Braden T Greer: Innovator in Neuroblastoma Prediction
Introduction
Braden T Greer is an accomplished inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of medical research, particularly in the area of neuroblastoma, a type of cancer that primarily affects children. His innovative work focuses on utilizing gene expression profiling and artificial neural networks to predict clinical outcomes for patients suffering from this disease.
Latest Patents
Braden T Greer holds a patent for the "Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma." This invention outlines a method for predicting patient outcomes by obtaining experimental data on gene selections. The gene selection serves to forecast the outcome of a neuroblastoma patient when compared to similar selections from non-neuroblastoma cells or different neuroblastoma cells. Additionally, the invention includes a method for targeting at least one product of a gene through the administration of a therapeutic agent. This groundbreaking approach also emphasizes the use of gene selection for predicting patient outcomes in neuroblastoma cases. He has 1 patent to his name.
Career Highlights
Braden T Greer is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution allows him to contribute to vital research that can improve patient care and treatment outcomes for those affected by neuroblastoma.
Collaborations
Throughout his career, Braden has collaborated with notable colleagues, including Javed Khan and Jun Stephen Wei. These partnerships have further enhanced the impact of his research and innovations in the medical field.
Conclusion
Braden T Greer is a pioneering inventor whose work in predicting clinical outcomes for neuroblastoma patients showcases the intersection of technology and medicine. His contributions are vital for advancing treatment strategies and improving patient prognoses.